Innovative clinical supply solutions
In today’s challenging environment, every clinical study is different and changes can occur during project development which require unique, responsive solutions. Catalent offers flexible services designed to keep studies moving.
Catalent has over 25 years’ experience in providing comprehensive clinical supply services, and has supported over 5,000 trials globally. Through eight cGMP clinical supply facilities across the U.S., Europe and Asia-Pacific region, and a global network of 50+ depots with a combined capacity of more than 1,400,000 cubic feet of controlled temperature space, Catalent manages more than 150,000 shipments per year to over 80 countries.
Catalent’s innovative FastChain™ demand led supply solution enables clinical sites to receive patient kits within a matter of days instead of weeks and can reduce clinical waste from more than 200% to less than 20%.
Catalent offers customers a full range of tailored solutions designed to address today’s complex clinical supply challenges, from clinical supply management and forecasting, comparator and reference product sourcing, primary and secondary packaging, labelling, clinical storage from controlled room temperature to cryogenic, global cold chain distribution, and clinical returns and destruction.
Speciality handling services are available for temperature, light and oxygen sensitive products, DEA Schedule I-V controlled drug substances and potent/cytotoxic products.
Catalent. More products. Better treatments. Reliably supplied™.
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
Navigating Annex 1 for Early Phase Sterile Fill Finish in Clinical Supplies
November 21st 2024Stay compliant with Annex 1 for early phase sterile fill finish processes. Discover how to implement robust contamination control strategies, integrate isolator technology, and conduct integrity testing to meet stringent European Union standards. The guide provides a comprehensive look at key elements such as PUPSIT, critical zone controls, and monitoring and training for aseptic processes.
Your Ultimate Guide for CMC Testing Support for Gene and Cell Therapy
November 21st 2024Explore the complexities of gene and cell therapy development with our comprehensive guide to Chemistry, Manufacturing, and Controls (CMC) testing. Learn how our expertise ensures the safety, potency, and quality of advanced therapies, supporting your journey from product development through regulatory approval.
